1. Review the evidence supporting the link between the gut microbiota and its effect on anti-cancer treatment
  2. Discuss strategies to modulate the gut microbiome to optimize efficacy of immunotherapy
  3. Consider potential mechanism by which the gut microbiome regulates immune response


  1. Provide an overview of pH-negative MPNS in accelerated phase and blast phase
  2. Discuss molecular mechanisms behind the development of blast phase
  3. Discuss treatment options and assessment of response to treatment
Session date: 
06/24/2019 - 12:00pm to 1:00pm CDT
5841 South Maryland Avenue, MC2115
MC2115 HemOnc Conference Room E-215
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Carolina Soto Chervin, MD, PhD and Anand A. Patel, MD